17β-Hydroxysteroid Dehydrogenase Activity Correlates with the Type-2 17β-Hydroxysteroid Dehydrogenase mRNA Abundance in Human Meningioma Tumors

Neuroendocrinology

Volumn 64, Issue 1, 1996, Pages 70-78

  Carsol, Jean Louis ^a   Adamski, Jerzy ^b   Guirou, Olivier ^a   Gérard, Henriette ^a   Martin, Pierre Marie ^a   de Launoit, Yvan ^c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

17 Hydroxysteroid dehydrogenase; Clinical neuroendocrinology; Gene expression; Meningioma

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; MESSENGER RNA; PLACENTA ENZYME; PROGESTERONE RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ADULT; AGE; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME SUBSTRATE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MALE; MENINGIOMA; NEUROENDOCRINOLOGY; NORTHERN BLOTTING; OXIDATION; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS;

17-HYDROXYSTEROID DEHYDROGENASES; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0029931104     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127101     Document Type: Article

References (35)

1. Russel DS, Rubinstein U: Pathology of Tumors of the Nervous System, London, Arnold, 1989, pp 449-505.
2. Burger PC, Vogel FS: Surgical Pathology of the Nervous System and Its Coverings, New York, Wiley, 1991, pp 67-68.
3. Weyand RD, MacCarty CS, Wilson RB: The effect of pregnancy on intracranial meningiomas occuring about optic chiasma, Surg Clin North Am 1951:31:1225-1233.
4. Schoenberg BS, Christine BW, Whisnant JP: Nervous system neoplasms and primary malignancies of other sites, The unique association between meningiomas and breast cancer, Neurology 1975;25:705-712.
5. Yu ZY, Wrangc O, Haglung B, Granholm L, GustalTson JA: Estrogen and progestin receptors in intracranial meningiomas, J Steroid Biochem 1982:16:451-456.
6. Davis C: Meningiomas and sex hormones, Eur J Cancer 1990;8:859-860.
7. Koehorst SGA, Jacobs HM, Tilanus MGJ, Bouwens AGM, Thijssen JHH, Blankenstcin MA: Aberrant oestrogen receptor species in human meningioma tissue, J Steroid Biochem Mol Biol 1992:43:57-61.
8. Maxwell M, Galtnopoulos T, Neville-Golden J, Antoniades HN: Expression of androgen and progesterone receptors in primary human meningiomas, J Neurosurg 1993;78:456-462.
9. Weisman AS, Ragnet SS, Kcllv PA: Characterization of the epidermal growth factor receptor in human meningioma, Cancer Res 1987;47: 2172-2176.
10. Kopcr JW, Foekens JA, Brackman R, Lamberts SWJ: Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells, Cancer Res 1990:50:2604-2607.
11. Davidson NE, Lippman ME: The role of estrogens in growth regulation of breast cancer, Oncogenesis 1989;1:89-111.
12. Reed MJ: Oestradiol-17fJ-hydroxysteroid dehydrogenase: Its family and function, J Endocrinol 1991;129:163-165.
13. Martel C, Rheaumc E, Takahashi M, Trudel C, Couet J, Luu-The V, Simard J, Labrie F: Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues, J Steroid Biochem Mol Biol 1992:41: 597-603.
14. Blomquist CH, Lindemann NJ, Hakanson EY: 17p-Hydroxystcroid and 20a-hydroxysteroid dehydrogenase activities of human placenta microsomes: Kinetic evidence for two enzymes differing in substrate specificity, Arch Biochem Biphys 1985:239:206-215.
15. Peltoketo H, Isomaa V, Maentausta O, Vihko R: Complete amino acid sequence of human placental 17p-hydroxystcroid dehydrogenase deduced from cDNA, FEBS Lett 1988:239:73-77.
16. Luu-The V, Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Leblanc G, Cote J, Berube D, Gagne R, Labrie F: Characterization of cDNAs for human estradiol 1713-dehydrogenase and assignment of the gene to chromosome 17: Evidence of two mRNA species with distinct S'-tcrmini in human placenta, Mol Endocrinol 1989;3:1301-1309.
17. Luu-The V, Labrie C, Simard J, Lachance Y, Zhao HF, Couet J, Leblanc G, Labrie F: Structure of two in tandem human 17-hydroxvste-roid dehydrogenase genes, Mol Endocrinol 1990;4:268-275.
18. Dumont M, Luu-The V, de Launoit Y, Labrie F: Expression of human l7β-hydroxysteroid dehydrogenase in mammalian cells, J Steroid Biochem Mol Biol 1992:41:605-608.
19. Wu L, Einstein M, Geisslcr WM, Chan HK, Elliston KO, Andersson S: Expression, cloning and characterization of human 17[J-hydroxy-steroid dehydrogenase type 2, a microsomal enzyme possessing 20u-hydroxystcroid dehydrogenase activity, J Biol Chem 1993:268: 12966-12969.
20. Carsol JL, Martin PM, de Launoit Y: Characterization of 17p-hydroxysteroid dehydrogenase activity and mRNA abundance in human meningioma tumors, Neuroendocrinology 1994;60:445-451.
21. Geissler W, Davis D, Wu L, Bradshaw K, Patel S, Mendonca B, Elliston K, Wilson J, Russel D, Andersson S: Male pseudohermaphroditism caused by mutations of testicular i 7p-hy-droxysteroid dehydrogenase 3, Nature Genet 1994;7:34-39.
22. Adamski J, Normand T, Leenders F, Monte D, Beguc A, Stehclin D, Jungblut PW, de Launoit Y: Molecular cloning of a novel widely expressed human 80 kDa 17-hydroxysteroid dehydrogenase 4, Biochem J 1995:311:437-443.
23. Le Goff JM, Martin PM: Totally automatic combined system comprising an HPLC apparatus and on-line radiodetector (flo-one) for routine analysis of prostatic enzyme activities, Prog HPLC 1988;3:79-91.
24. Grimaux M, Magdclcnat H, Poisson M, Cha-mourard JM, Barritault D, Foncin JF, Philip-pon J: EGF receptors (epidermal growt h factor) and steroid receptors in human meningioma, Rev Neurol (Paris) 1988:144:96-103.
25. Adamski J, Husen B, Marks F, Jungblut PW: Purification and properties of oestradiol I7p-dehydrogcnase extracted from cytoplasmic vesicles of porcine endometrial cells, Biochem J 1992;288:375-381.
26. Leenders F, Adamski J, Husen B, Thole HH, Jungblut PW: Molecular cloning and amino acid sequence of the porcine 17-estradiol de-hydrcgenasc, Eur J Biochem 1994:222:221 —227.
27. Segal D, Shilo BZ: Tissue localization ofDrosophila melanogaster rastranscripts during development, Mol Cell Biol 1986;6:2241-2248.
28. Ouafik LH, May V, Saffen DW, Eipper BA: Thyroid hormone regulation of peptidylglycine a-amidating monooxygenasc expression in anterior pituitary gland, Mol Endocrinol 1990:4:1497-1505.
29. Monte D, Groux H, Raharinivo B, Plouvier B, Dewulf J, Clavel T, Grangette C, Torpier G, Auriault C, Capron A, Amcisen JC: Productive HIV-1 infection of megacaryocytic cells is enhanced by TNFa, Blood 1992;79:2670-2678.
30. Takahashi T, Eitzman B, Bossert NL, Waimer D, Sparrow K, Flanders KC, McLachlan J, Nelson KG: Transforming growth factors pi, p2, and p3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogen-regulated genes, Cell Growth Diff 1994:5: 919-935.
31. Chajry N, Martin PM, Pages G, Cochet C, Afdel K, Bcrthois Y: Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferation, Biochem Biophys ResCommun 1994;203:984-990.
32. Jones NR, Rossi ML, Gregoriou M, Hughes JT: Epidermal growth factor receptor expression in 72 meningiomas, Cancer 1990:66:152— 155.
33. Follow K, Lubbert H, Boquoi E, Krcutzer G, Jeske R, Pollow B: Studies on 17p-hydroxyste-roid dehydrogenase in human endometrium and endometrial carcinoma, I, Subcellular distribution and variations of specific enzyme activity, Acta Endocrinol 1975;79:134-145.
34. Tseng L, Gusberg S, Gurpide E: Estradiol receptor and 17p-dehydrogenase in normal and abnormal endometrium, Ann NY Acad Sci 1977;286:190-198.
35. Adams EF, Coldham NG, James VHT: Steroidal regulation of oestradiol-17p dehydrogenase activity of the human breast cancer cell line MCF-7, J Endocrinol 1988:118:149-154.